Search for: "Apotex Inc."
Results 521 - 540
of 674
Sorted by Relevance
|
Sort by Date
18 Jul 2007, 5:01 am
All opinions are precedential unless otherwise indicated.Pharmasterm Therapeutics, Inc. v. [read post]
19 Mar 2024, 8:54 am
Apotex, Inc., 480 F.3d 1348 (Fed. [read post]
14 Jan 2010, 11:09 am
Apotex Corp., 316 F.3d 1348, 1365 (Fed. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC blog) Sustiva (Efavirenz) - Brazil: Compulsory licensed Efavirenz will be manufactured by public Brazilian laboratories by end of 2008 (IP tango) General A patent question of patents: Prof T Pogge's 'Health Impact Fund' alternative licensing system (Patent… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
18 Jul 2008, 10:12 am
Apotex Inc., 2008 WL 927848 (3d Cir. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) Please join the… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
5 Mar 2010, 9:10 pm
Apotex, Inc., 480 F.3d 1348, 1362 (Fed. [read post]
19 Jan 2024, 4:00 am
In other contexts, there have been concerns that double patenting may increase burdens under the Notice of Compliance regime for pharmaceuticals – see for example, Glaxosmithkline Inc. v Apotex Inc, 2003 FCT 687 at 90: “The existence of additional patents allows the patent-holder to bring additional applications, thereby obtaining multiple injunctive periods. [read post]
9 Nov 2015, 4:00 am
Inc. v. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
4 Aug 2011, 7:40 am
Apotex Corp., 439 F.3d 1312, 1319 (Fed. [read post]
17 Mar 2020, 1:32 pm
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
15 Sep 2009, 10:54 pm
Apotex Corp., 439 F.3d 1312, 1317 (Fed. [read post]
17 Apr 2008, 10:39 am
Apotex Inc., ___ F.3d ___, 2008 WL 927848 (3d Cir. [read post]
24 May 2011, 12:13 am
Apotex, Inc., 550 F.3d 1075, 1082 (Fed. [read post]
24 Jan 2012, 6:34 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
24 Aug 2011, 9:00 pm
Apotex, Inc., 470 F.3d 1368, 1375 (Fed. [read post]
17 May 2015, 4:00 am
Apotex Inc., 2014 FCA 66 (35886) Judgment rendered April 20, 2015 The Chief Justice: “We are all of the view to dismiss the appeal substantially for the reasons of the majority of the Court of Appeal. [read post]
